Definium Therapeutics, Inc. (DFTX)
22.13
+0.20
(+0.91%)
USD |
NASDAQ |
Apr 15, 16:00
22.10
-0.03
(-0.14%)
After-Hours: 18:02
Definium Therapeutics Market Cap : 2.206B for April 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pulse Biosciences, Inc. | 1.320B |
| RxSight, Inc. | 297.74M |
| Plus Therapeutics, Inc. | 38.67M |
| Viridian Therapeutics, Inc. | 1.520B |
| Nutriband, Inc. | 49.47M |
Market Cap Related Metrics
| PEG Ratio | -1.255 |
| Price to Book Value | 6.639 |
| Price | 22.13 |
| Earnings Yield | -9.35% |
| PEGY Ratio | -1.255 |